Home LiteratureArticle Details
PMID: 14972518 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses.

Virology ·Vol. 318 ·No. 2 ·2004-01-20 ·Pages 493-506

Gzyl J, Bolesta E, Wierzbicki A, Kmieciak D, Naito T, Honda M, Komuro K, Kaneko Y, Kozbor D

Abstract

Induction of cross-reactive cellular and humoral responses to the HIV-1 envelope (env) glycoprotein was examined after DNA immunization of BALB/c mice with gp140(89.6)-derived constructs exhibiting partial or complete deletions of the V1, V2, and V3 domains. It was demonstrated that specific modification of the V3 loop (mV3) in combination with the V2-modified (mV2) or V1/V2-deleted (DeltaV1/V2) region elicited increased levels of cross-reactive CD8(+) T cell responses. Mice immunized with the mV2/mV3 or DeltaV1/V2/mV3 gp140(89.6) plasmid DNA were greater than 50-fold more resistant to challenge with recombinant vaccinia virus (rVV) expressing heterologous env gene products than animals immunized with the wild-type (WT) counterpart. Sera from mV2/mV3- and DeltaV1/V2/mV3-immunized mice exhibited the highest cross-neutralizing activity and displayed intermediate antibody avidity values which were further enhanced by challenge with rVV expressing the homologous gp160 glycoprotein. In contrast, complete deletion of the variable regions had little or no effect on the cross-reactive antibody responses. The results of these experiments indicate that the breadth of antibody responses to the HIV-1 env glycoprotein may not be increased by removal of the variable domains. Instead, partial deletions within these regions may redirect specific responses toward conserved epitopes and facilitate approaches for boosting cross-reactive cellular and antibody responses to the env glycoprotein.

MeSH Terms
Amino Acid Sequence Animals Antibodies, Viral/immunology Antibody Affinity CD8-Positive T-Lymphocytes/immunology Cross Reactions Disease Models, Animal Gene Deletion Glycoproteins/genetics,immunology HIV Envelope Protein gp160/immunology HIV Infections/immunology,prevention & control HIV-1/genetics,immunology Immunization Mice Mice, Inbred BALB C Molecular Sequence Data Spleen/immunology Vaccines, DNA/genetics,immunology
Chemicals
Antibodies, Viral GP 140 Glycoproteins HIV Envelope Protein gp160 Vaccines, DNA
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Gzyl Jaroslaw
Department of Immunology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Bolesta Elizabeth
Wierzbicki Andrew
Kmieciak Dariusz
Naito Toshio
Honda Mitsuo
Komuro Katsutoshi
Kaneko Yutaro
Kozbor Danuta
Article Info
Journal
Virology
Abbr.
Virology
ISSN
0042-6822
Published
2004-01-20
Pages
493-506
Language
English
Region
United States
NLM ID
0110674
Subset
IM
Grants
NIAID NIH HHS · R21AI54163-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com